Jeeshan Chowdhury is an MD/PhD and studied at Oxford as a Rhodes Scholar. He is a seasoned entrepreneur, having founded and sold ListRunner, a digital tool for frontline clinical teams, and founded Journey Colab, a company dedicated to advancing psychedelic medicine for substance use treatment. Journey Colab was part of Sam Altman's inaugural cohort of Apollo Projects Fund.

Anna Martirosyan spent the last several years advancing cutting-edge treatments for mental health at Journey Colab, a company advancing psychedelic medicines for substance use treatment. Prior, she spent several years supporting growth equity firms in healthcare and software investing at Bain & Co. She holds a BA in Psychology, with an emphasis in neuroscience, and BA in Economics from the University of California, Berkeley.

Dr. Carreon is a board-certified psychiatrist who received his psychiatric training at Stanford University.  He has been practicing since 2014, with a specialty in TMS and other neuromodulation techniques.  In 2018, he founded Acacia Clinics, one of the nation's leading treatment and research centers specializing in TMS and other novel treatments.  For the past five years, Dr. Carreon has also conducted research at Stanford in the Etkin Neuroscience Lab, primarily focusing on the underlying physiology of psychiatric disorders.

Dr. Meng is a physician who trained at Stanford University. In 2018, alongside Dr. Carreon, he founded Acacia Clinics one of the nation's leading treatment and research centers specializing in TMS and other novel treatments. Prior, he served  as the Chief Technology Officer of Ameda, Inc., a privately-held medical device company in the mother-baby space.  While at Stanford, Dr. Meng was also the Clinical Lead at Embrace, Inc., a start-up medical device company, also in the mother-baby space.